KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-9

  1. Pbnewby
    7,515 Posts.
    lightbulb Created with Sketch. 337
    clock Created with Sketch.
    31/10/16
    10:07
    Post #: 20242157
    Well they've done what was expected - I have no idea yet about what they've bought but from a strategic perspective - they have just bought in new shareholders and if the new compounds are already in the clinic then they are officially a clinical drug company. Hope they used mainly scrip and not cash!
    NRT Price at posting: 8.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.